Results 11 to 20 of about 5,464,336 (251)

Contribution of adverse events to death of hospitalised patients [PDF]

BMJ Open Quality, 2019
Background There is no standardised method to investigate death as a patient safety indicator and we need valid and reliable measurements to use adverse events contributing to death as a quality measure.Objective To investigate the contribution of severe
Ellinor Christin Haukland, Kjersti Mevik, Christian von Plessen, Carsten Nieder, Barthold Vonen   +4 more
doaj   +2 more sources

Measuring severe adverse events and medication selection using a “PEER Report” for nonpsychotic patients: a retrospective chart review

Neuropsychiatric Disease and Treatment, 2012
Daniel A Hoffman,1 Charles DeBattista,2 Rob J Valuck,3 Dan V Iosifescu41Neuro-Therapy Clinic, Inc, Denver, CO, USA; 2Stanford University School of Medicine, Palo Alto, CA, USA; 3University of Colorado, SKAGES School of Pharmacy and Pharmaceutical ...
Hoffman DA, DeBattista C, Valuck RJ, Iosifescu DV   +3 more
doaj   +1 more source

Adverse events registration in clinical trial participants with severe acute brain injury: a Delphi consensus study

Acta Neurochirurgica
Purpose Understanding the adverse effects of an intervention is important for evaluating its overall effect. Clinical trials mainly focus on the benefits of interventions with a risk of overlooking potential harms.
Trine Hjorslev Andreasen, Christian Gunge Riberholt, Anne-Sophie Worm Fenger, Anton Lund, Alexandra Vassilieva, Markus Harboe Olsen, Kirsten Møller   +6 more
doaj   +2 more sources

Evaluating and Optimising the Retrieval of Research Evidence for Systematic Reviews of Adverse Drug Effects and Adverse Drug Reactions [PDF]

, 2013
Systematic reviews can provide timely, reliable evidence on which to make informed decisions. In order to make balanced decisions, information is not only needed on the benefits of an intervention, but also on its adverse effects.
Golder, Su
core   +6 more sources

Drug-use patterns and severe adverse events with disease-modifying drugs in patients with multiple sclerosis: a cohort study based on German claims data

Neuropsychiatric Disease and Treatment, 2019
Alexandra Simbrich,1 Jasmine Thibaut,1 Laura Khil,1,2 Klaus Berger,1 Oliver Riedel,3 Niklas Schmedt3,41Institute of Epidemiology and Social Medicine, University of Münster, 48149 Münster, Germany; 2Cancer Registry North Rhine-Westphalia, 44801,
Simbrich A, Thibaut J, Khil L, Berger K, Riedel O, Schmedt N   +5 more
doaj   +1 more source

Adverse Events and Safety Profile of the COVID-19 Vaccines in Adolescents: Safety Monitoring for Adverse Events Using Real-World Data

Vaccines, 2022
A COVID-19 vaccine BNT162b2 (Pfizer-BioNTech) has recently been authorized for adolescents in the US. However, the impact of adverse events on adolescents after vaccination has not been fully investigated.
Chae Won Lee, Soonok Sa, Myunghee Hong, Jihyun Kim, Sung Ryul Shim, Hyun Wook Han   +5 more
doaj   +1 more source

Major adverse cardiovascular events are associated with necroptosis during severe COVID-19

Critical Care, 2023
Background The mechanisms used by SARS-CoV-2 to induce major adverse cardiac events (MACE) are unknown. Thus, we aimed to determine if SARS-CoV-2 can induce necrotic cell death to promote MACE in patients with severe COVID-19.
Rosana Wiscovitch-Russo, Elsa D. Ibáñez-Prada, Cristian C. Serrano-Mayorga, Benjamin L. Sievers, Maeve A. Engelbride, Surya Padmanabhan, Gene S. Tan, Sanjay Vashee, Ingrid G. Bustos, Carlos Pachecho, Lina Mendez, Peter H. Dube, Harinder Singh, Luis Felipe Reyes, Norberto Gonzalez-Juarbe   +14 more
doaj   +1 more source

Oral Treatment With Bisphosphonates of Osteoporosis Does Not Increase the Risk of Severe Gastrointestinal Side Effects: A Meta-Analysis of Randomized Controlled Trials

Frontiers in Endocrinology, 2020
IntroductionBisphosphonates (BPs) are first-line therapy for osteoporosis. Adherence is usually low in chronic, asymptomatic diseases, but gastrointestinal (GI) side-effects can also contribute to low adherence in BP therapy and may necessitate a review ...
Zsuzsa Réka Dömötör, Zsuzsa Réka Dömötör, Nóra Vörhendi, Lilla Hanák, Péter Hegyi, Szabolcs Kiss, Szabolcs Kiss, Endre Csiki, Lajos Szakó, Andrea Párniczky, Bálint Erőss   +10 more
doaj   +1 more source

Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada [PDF]

, 2003
Although information on efficacy and adverse drug reactions is lacking, ribavirin has been used empirically for the treatment of severe acute respiratory syndrome (SARS). We report common adverse events in 110 patients with suspected or probable SARS who
Dresser, L., Linda Dresser, Larissa Matukas, Elizabeth J. Phillips, Phillips, E.J., Matukas, L., Sandra R. Knowles, Knowles, S.R.   +7 more
core   +1 more source

Regular treatment with formoterol for chronic asthma: serious adverse events [PDF]

, 2012
Epidemiological evidence has suggested a link between beta(2)-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are safe ...
Christopher J Cates, Cates, MJ, Matthew J Cates, Cates, CJ   +3 more
core   +1 more source